Summary of Henry Schein FY Conference Call (March 10, 2026) Company Overview - **Company**: Henry Schein (NasdaqGS:HSIC) - **Industry**: Dental distribution and healthcare products Key Highlights from Q4 2025 - **Dental Business Growth**: Notable improvement in dental distribution growth in both the U.S. and international markets, indicating market share gains [4][5] - **Equipment Sales**: U.S. dental equipment sales exceeded 10% growth in Q4, significantly outpacing market trends, reflecting customer confidence in practice investments [5][6] - **Market Share**: Successful promotional programs contributed to growth, with a focus on new customer acquisition [5][14] Financial Guidance for 2026 - **Earnings Per Share (EPS)**: Guidance set at $5.23-$5.37, representing a 5%-8% growth [8] - **Cost Management**: Anticipated costs related to value creation initiatives in the first half of the year, with earnings growth expected to be more pronounced in the second half [9] Segment Performance - **Dental Specialty**: Strong growth in dental implants, particularly in Europe, with steady growth in the U.S. driven by a new value implant [7][41] - **Technology**: Henry Schein One holds approximately 50% market share in dental practice management systems, with new product launches aimed at improving operational efficiency for customers [7][8] - **Merchandise Growth**: Achieved 3%-4% growth in merchandise, attributed to promotional activities and recruitment of experienced sales representatives [36] Innovation and Market Trends - **Digital Transition**: Many dental practices have yet to fully embrace digital technologies, indicating a long runway for growth in digital equipment sales [22][29] - **Intraoral Scanners**: Price reductions in scanners are attracting more practices, facilitating further sales of digital equipment [29][31] Leadership Changes and Strategic Direction - **New CEO**: Fred Lowery appointed as CEO, succeeding Stanley Bergman, with a focus on fresh perspectives and strategic execution [53][56] - **KKR Investment**: KKR now holds a 19.9% stake in the company, providing new board members and a collaborative culture that supports value creation initiatives [57][60] Capital Deployment Strategy - **Share Buybacks**: $850 million in stock repurchases executed, indicating belief in the stock's undervaluation [66] - **M&A Activity**: Slower pace of acquisitions noted, with a focus on share repurchases as a priority for capital deployment [68] Market Outlook - **Positive Market Sentiment**: Signs of optimism in the dental market, with peers showing recovery from previous challenges [71] - **Customer Confidence**: Equipment sales results suggest a confident customer base willing to invest in their practices, positioning Henry Schein favorably for future growth [72]

Macro Environment Overview - The macro environment in the dental industry has remained relatively stable, with patient traffic data indicating consistent levels throughout the year [1] - Patient traffic is considered a key indicator for merchandise sales and inventory turnover [1] Impact of Interest Rate Changes - The recent cuts in U.S. interest rates are viewed as a significant macroeconomic factor that may provide short-term opportunities for increased equipment sales [2] - Larger dollar equipment sales are often financed through leasing or other financing methods, suggesting potential for growth in this area due to lower interest rates [2]

Summary of Henry Schein 2025 Conference Call Company Overview - **Company**: Henry Schein (NasdaqGS: HSIC) - **Date of Conference**: September 24, 2025 Key Industry Insights - **Macro Environment**: The U.S. is experiencing a reduction in interest rates, which is expected to positively impact equipment sales and the establishment of new dental practices, particularly by Dental Service Organizations (DSOs) [4][5][22] - **Patient Traffic**: Patient traffic in dental practices has remained stable, serving as a key indicator for merchandise sales [3][4] - **International Growth**: There is a slight uptick in international business, especially in Mainland Europe, following a period of energy price increases [7] Core Company Strategies and Performance - **Sales Growth**: Promotional activities in Q2 have started to yield positive results, with double-digit growth in customer engagement and sales [11][9] - **Customer Retention**: Efforts to engage episodic customers through field sales consultants are aimed at increasing market share and customer loyalty [12][14] - **Field Sales Force**: The addition of experienced sales representatives is ongoing, with expectations of ramping up to full productivity within 12 months [15][16][17] Financial Outlook - **EPS Growth**: The company aims for high single-digit EPS growth in 2026, with various macroeconomic factors influencing this target, including interest rates and unemployment [19][20][22] - **Cost Optimization**: Henry Schein is undertaking value creation projects to optimize gross profit and general & administrative costs, with expected benefits starting in 2026 [23][25][26] Market Dynamics - **Pricing and Tariffs**: The company is navigating the impact of tariffs on private label products, which may necessitate price increases while maintaining competitiveness [31][32] - **Implant Market**: The value implant market is growing faster than the premium segment in the U.S., with DSOs increasingly adopting value implants for straightforward procedures [34][38][46] Medical Segment Insights - **Vaccine Demand**: The flu vaccine remains a significant product, with expectations for normal demand levels. The COVID vaccine is less impactful due to low margins [56][58] - **Medical Business Growth**: The medical segment has seen a 6% growth, driven by pharmaceuticals and point-of-care diagnostic kits, with a notable home health business growing at a faster pace [64][65] Technology Business Performance - **Growth Rates**: The core practice management systems are performing well, but peripheral products are dragging down overall growth. Consolidation of brands is expected to improve growth rates [66][68][70] Capital Deployment Strategy - **Share Repurchase Program**: A $750 million share repurchase program has been announced, indicating a strategic focus on capital deployment while remaining opportunistic regarding M&A [71][73] Additional Considerations - **Market Expansion**: The company is optimistic about the expansion of the market for dental practices, particularly with the potential for new practice builds as interest rates decline [5][6] - **Customer Engagement**: The focus on educating customers about profitability and operational efficiency is seen as a key driver for long-term relationships and market share growth [12][14]